Share This Page
Details for Patent: 4,451,458
✉ Email this page to a colleague
Summary for Patent: 4,451,458
Title: | Method for the treatment of post-operative thrombosis |
Abstract: | The invention provides novel pharmaceutical compositions useful in the treatment of thrombosis in mammals, comprising a mixture of dihydroergotamine or a related ergot alkaloid and heparin. |
Inventor(s): | Buhlmann; Hans (Nuremberg, DE), Welzel; Dieter (Nuremberg, DE) |
Assignee: | Sandoz Ltd. (Basel, CH) |
Application Number: | 06/379,272 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Patent landscape, scope, and claims: | Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis IntroductionWhen navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of patent scope, claim management, and the broader patent landscape, using U.S. Patent 4,451,458 as a case study. What is a Patent?A patent is a form of intellectual property that gives its owner the right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date of the patent application. Patents are granted by the United States Patent and Trademark Office (USPTO)[5]. Patent ScopePatent scope refers to the breadth and depth of protection afforded by a patent. It is a critical aspect of patent quality and is often debated in the context of patent breadth and validity. Metrics for Measuring Patent ScopeResearchers have developed simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3]. Patent ClaimsPatent claims are the legal definitions of the invention and define the scope of protection. Here’s a detailed look at how claims are structured and managed. Types of Claims
Claim ManagementEffective claim management is key to maximizing the value of a patent. Here are some strategies:
Case Study: U.S. Patent 4,451,458While specific details about U.S. Patent 4,451,458 are not provided in the sources, we can apply the general principles of patent scope and claim management to understand its significance. Claim StructureTo analyze the scope of U.S. Patent 4,451,458, one would need to examine its claim structure. This includes identifying the independent claims, which define the broadest scope of the invention, and the dependent claims, which narrow down the scope further. Scope of ProtectionThe scope of protection for U.S. Patent 4,451,458 would be determined by the language of its claims. Narrower claims would provide more specific protection, while broader claims would offer a wider scope of protection but might be more susceptible to challenges during the examination process[3]. Patent LandscapeThe patent landscape is influenced by various factors, including legal and economic conflicts, cross-licensing agreements, and antitrust laws. Cross-Licensing AgreementsCross-licensing among different industries is a common practice that can affect the patent landscape. This involves companies licensing their patents to each other, which can lead to complex legal and economic relationships. For example, cross-licensing can restrict the scope of licenses to particular fields of activity and may raise antitrust concerns[4]. Antitrust LawsPatent licensing agreements must comply with antitrust laws, such as the Sherman and Clayton Acts. These laws aim to prevent monopolies and ensure fair competition. The legality of restricting the scope of licenses and the validity of "tie-in" clauses are critical issues in this context[4]. Economic and Legal ImplicationsThe economic and legal implications of patent scope and claims are significant. Innovation IncentivesThe breadth and clarity of patent claims can influence innovation incentives. Overly broad patents with decreased clarity can lead to increased licensing and litigation costs, diminishing the incentives for innovation[3]. Litigation and LicensingThe strategic management of claims can enhance a patent’s defensive capabilities and its value in potential licensing discussions or infringement disputes. Each claim can be viewed as a unique tool for protecting different facets of the invention[5]. Best Practices in Claim ManagementTo maximize the value of a patent, several best practices in claim management should be followed:
Key Takeaways
FAQsQ: What is the significance of independent claims in a patent? A: Independent claims define the broadest scope of the invention and stand alone without depending on other claims. Q: How does the USPTO handle claim amendments during the patent prosecution phase? A: The USPTO requires claims to be amended to align with patentability requirements, often involving the consolidation of multiple dependent claims into fewer, broader independent claims. Q: What are the economic implications of overly broad patents? A: Overly broad patents can lead to increased licensing and litigation costs, diminishing the incentives for innovation. Q: How can cross-licensing agreements affect the patent landscape? A: Cross-licensing agreements can restrict the scope of licenses to particular fields of activity and may raise antitrust concerns. Q: Why is it important to utilize the full quota of claims in a patent application? A: Utilizing the full quota of claims maximizes the patent’s breadth and flexibility without incurring additional costs, enhancing its defensive capabilities and value. Sources
More… ↓ |
Drugs Protected by US Patent 4,451,458
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available in table | ||||||||||||||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |